Growth Metrics

Pacific Biosciences Of California (PACB) Operating Income (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 79.71%
Dec 31, 2025 -5.97%
Sep 30, 2025 13.32%
Jun 30, 2025 89.54%
Mar 31, 2025 -180.30%
Dec 31, 2024 -138.82%
Sep 30, 2024 63.56%
Jun 30, 2024 -116.13%
Mar 31, 2024 7.07%
Dec 31, 2023 -6.13%
Sep 30, 2023 -12.73%
Jun 30, 2023 19.81%
Mar 31, 2023 -4.79%
Dec 31, 2022 -16.70%
Sep 30, 2022 -9.79%
Jun 30, 2022 12.32%
Mar 31, 2022 -19.86%
Jun 30, 2021 -11.46%
Mar 31, 2021 -40.59%
Dec 31, 2020 0.82%
Sep 30, 2020 -2.77%
Jun 30, 2020 28.08%
Mar 31, 2020 -82.56%
Dec 31, 2019 36.27%
Sep 30, 2019 -15.32%
Jun 30, 2019 19.09%
Mar 31, 2019 1.60%
Dec 31, 2018 -24.13%
Sep 30, 2018 -13.45%
Jun 30, 2018 9.20%
Mar 31, 2018 -16.66%
Dec 31, 2017 4.82%
Sep 30, 2017 11.56%
Jun 30, 2017 -4.67%
Mar 31, 2017 -30.35%
Dec 31, 2016 -6.81%
Sep 30, 2016 7.39%
Jun 30, 2016 2.67%
Mar 31, 2016 -1,648.12%
Dec 31, 2015 -140.63%
Sep 30, 2015 123.01%
Jun 30, 2015 41.24%
Mar 31, 2015 -8.01%
Dec 31, 2014 -112.69%
Sep 30, 2014 54.03%
Jun 30, 2014 -0.31%
Mar 31, 2014 -7.30%
Dec 31, 2013 14.70%
Sep 30, 2013 0.31%
Jun 30, 2013 2.96%
Mar 31, 2013 5.01%
Dec 31, 2012 3.92%
Sep 30, 2012 -0.11%
Jun 30, 2012 18.01%
Mar 31, 2012 -21.25%
Dec 31, 2011 22.92%
Sep 30, 2011 -29.89%
Jun 30, 2011 35.19%
Mar 31, 2011 4.43%
Dec 31, 2010 10.09%
Sep 30, 2010 -24.55%